Michael Dixon is the President and CEO of UNeMed, the technology transfer and commercialization office for UNMC and UNO. He holds a doctorate in pathology and microbiology from UNMC and has previously worked in industry as a chemist. With the help of UNeMed, UNMC has been in the top 100 institutions receiving patents in each of the past four years. Dr. Dixon will speak on the importance of technology commercialization and how UNeMed helps research discoveries turn into products that impact healthcare.
Wednesday, September 15 at 12:00pm to 1:00pmVirtual Event